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The structure of F1-ATPase from Saccharomyces cerevisiae inhibited by the yeast
IF1 has been determined at 2.5 A˚ resolution. The inhibitory region of IF1 from
residues 1 to 36 is entrapped between the C-terminal domains of the aDP-
and bDP-subunits in one of the three catalytic interfaces of the enzyme.
Although the structure of the inhibited complex is similar to that of the
bovine-inhibited complex, there are significant differences between the struc-
tures of the inhibitors and their detailed interactions with F1-ATPase.
However, the most significant difference is in the nucleotide occupancy of the
catalytic bE-subunits. The nucleotide binding site in bE-subunit in the yeast
complex contains an ADP molecule without an accompanying magnesium
ion, whereas it is unoccupied in the bovine complex. Thus, the structure pro-
vides further evidence of sequential product release, with the phosphate and
the magnesium ion released before the ADP molecule.2. Introduction
The hydrolysis of ATP by the F-ATPase isolated from mitochondria is inhibited
by a small basic protein, known as IF1 [1]. When the purified enzyme was co-
reconstituted into phospholipid vesicles with bacteriorhodopsin, IF1 had no
effect on ATP synthesis, whereas ATP hydrolysis by the purified enzyme was
inhibited [2]. The binding of IF1 to the enzyme requires the hydrolysis of
ATP to drive the anticlockwise rotation of the central stalk (as viewed from
the membrane domain of the intact enzyme) and entrap the inhibitor in its
binding site. Bovine IF1, the most extensively characterized ATPase inhibitor
protein, consists of a chain of 84 amino acids [3,4]. Residues 21–83 are folded
into a long a-helix, and the active form is a dimer held together by an antipar-
allel coiled-coil of a-helices from residues 49 to 81 [5–7]. The inhibitory region
is found in residues 1–46 [8], and the dimeric inhibitor can inhibit two
F1-ATPase complexes simultaneously [9]. A monomeric form, prepared by
Bos taurus
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Rattus norvegicus
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Yarrowia lipolytica
Pichia jadinii 
Figure 1. Alignment of the sequences of residues 1–60 of bovine IF1, and the equivalent region of yeast IF1, with the same regions from other species. The purple,
green and yellow stripes denote identical, highly conserved and poorly conserved residues, respectively. The alignment was performed with CLUSTALW. The bars above
the sequences denote a-helical regions in the bovine protein. The yIF1 used in crystallization experiments contained the mutation E21A.
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2deleting residues 61–84, is also an effective inhibitor. The
structure of bovine F1-ATPase inhibited with this monomeric
inhibitor (known as F1-I1–60) shows the N-terminal region of
IF1 from residues 1–13 lying within the aqueous cavity sur-
rounding an a-helical coiled-coil in the g-subunit that forms
the rotor of F1-ATPase; residues 1–7 were unresolved and
residues 8–13 form an extended structure [8]. Residues 14–
18 are folded into a single turn of an a-helix, which interacts
with the coiled-coil region of the g-subunit; residues 19 and
20 link this short a-helix to the long a-helix of the inhibitor,
which extends outwards from residue 21 beyond the external
surface of the a3b3-domain of the enzyme. Residues 21–46 of
this long a-helix occupy a deep groove, formed mainly by
a-helices and loops in the C-terminal domains of the aDP-
and bDP-subunits in a catalytic interface of F1-ATPase, and
hydrophobic interactions between the inhibitor and the
bDP-subunit provide most of the binding energy [10].
The ATPase inhibitor protein from Saccharomyces cerevisiae
is 63 amino acids long. The poorly conserved N-terminal
region (residues 1–16; figure 1), is followed by a well-
conserved segment from residues 17 to 45, corresponding
to the long a-helix in the inhibitory region of the bovine
protein. However, the C-terminal segment responsible for
the formation of dimers in the bovine protein is truncated
and not conserved in the yeast protein.
As described here, the structure of yeast F1-ATPase inhibi-
ted with residues 1–53 of yeast IF1 (yI1–53) has been
determined at 2.5 A˚ resolution. Many features of this struc-
ture are similar to those of the structure of bovine F1-I1–60.
However, one significant difference is that the yeast inhibitor
has arrested the catalytic cycle of ATP binding and hydrolysis
followed by product release at an earlier stage in the cycle
than the bovine inhibitor. This structure provides independent
confirmation of a new intermediate in the catalytic cycle of
F1-ATPase, observed in a structure of bovine F1-ATPase [11],
which immediately precedes the formation of the ‘open’ or
‘empty’ state observed in the ‘ground state’ structure.3. Results
3.1. Oligomeric states of inhibitor proteins
The complex of yeast F1-ATPase inhibited with full-length
yeast IF1 was estimated by gel filtration chromatography to
have an apparent molecular mass of 385 kDa, whereas the
value for the complex between the bovine F1-ATPase and
full-length bovine IF1 was 670 kDa (figure 2). These dataare consistent with the yeast and bovine F1-IF1 complexes
being monomeric and dimeric, respectively, with the dimeric
bovine inhibitor bound to two F1-ATPase complexes, as
demonstrated before [6].
3.2. Structure determination
The inhibited complex between yeast F1-ATPase and yeast
I1–53, known as yF1-I1–53, was formed in the presence
of Mg-ATP as described in §5. Its structure (figure 3) was
determined by X-ray crystallography, and was solved by
molecular replacement (see §5) with data at 2.5 A˚ resolution.
The asymmetric unit contains two yF1-I1–53 complexes. Data
processing and refinement statistics are summarized in
table 1. The final model of yF1-I1–53 contains the following
residues: aE, 26–509; aTP, 25–406 and 412–509; aDP,
26–509; bE, 8–475; bTP, 7–475; bDP, 6–475; g, 1–59 and
71–276; d, 11–23 and 27–137; 1, 1–49 and 53–61 and
yI1–53, 1–36. The refined temperature factors suggested
the presence of a mixture of Mg-ATP (75%) and Mg-ADP
(25%) in the nucleotide binding site of the non-catalytic aE-
subunit, whereas the nucleotide binding sites in the aTP-,
bDP- and bTP-subunits all contained Mg-ADP only. The
nucleotide binding site of the aDP-subunit was occupied
almost entirely by Mg-ADP, but there was also evidence for
the presence of Mg-ATP at low occupancy. The bE-subunit
contained a bound ADP molecule only, and there was no
electron density corresponding to either bound phosphate
or a magnesium ion. The models of both assemblies in the
asymmetric unit contain the same residues and have the
same nucleotide occupancy. Their structures are essentially
identical (the r.m.s. value from a global superimposition
was 0.34 A˚; the values for individual subunits are between
0.01 and 0.02 A˚).
3.3. Structure of the yeast F1-IF1 complex
In the structure (figure 3), the resolved part of yeast I1–53 is
found between the C-terminal domains of the aDP- and bDP-
subunits. This region consists of an extended structure from
residues 1 to 16, bent into a loop from residues 6 to 16
(figure 4a), with residues 17–36 folded into an a-helix 29 A˚
long (figure 4b). Residues 17–35 of the a-helix are bound
into a deep groove between the C-terminal domains of the
aDP- and bDP-subunits (figure 4c). The polypeptide chain
beyond residue 36 presumably extends from the external sur-
face of the F1-domain. Residues 1–5 of the inhibitor are in the
aqueous chamber surrounding the g-subunit in the central
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Figure 2. Gel filtration chromatography of yeast and bovine F1-ATPase-IF1 complexes. The yeast and bovine enzymes were inhibited with the inhibitor protein from
S. cerevisiae (yF1) and with bovine IF1 (bIF1), respectively. (a) Column profiles of yF1–yIF1, active yF1 and bF1–bIF1 complexes, respectively. V0 is the void volume of
the column. (b) SDS–PAGE analysis of peaks 1, 2 and 3 from (a).
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3region of the F1-domain. Residue E2 makes a salt bridge with
residue aE-K361 in a-helix H (see Abrahams et al. [12] for
definition of secondary structure elements) in the nucleotide
binding region of the aE-subunit. Residues 6–16 form a
loop region held together by a salt bridge between residues
R9 and D15 of the inhibitor, and by a hydrogen-bonding net-
work involving residues S4, R9 and D15 of the inhibitor
(figure 4a). In this region, the structure of the yeast inhibi-
tor differs from that of the N-terminal region of the bovine
inhibitor bound to bovine F1-ATPase (figure 4b), reflecting
the difference in length between the yeast and bovine inhibi-
tors and the lack of sequence similarity in their N-terminal
regions (figure 1). Nonetheless, the two N-terminal regions
occupy a similar space in the respective F1-ATPases
(figure 4b). The loop motif in residues 6–16 of the yeast
inhibitor protein replaces the motif consisting of the a-helical
turn and the following extended region in the bovine protein.
However, both motifs are in contact with the N-terminal
a-helix of the g-subunit. From residue 17, the yeast inhibitor
forms an a-helix that extends to residue 36 in the structure.
The bovine protein contains a similar a-helix beginning at
residue 21, one residue before the yeast protein in the aligned
sequences and structures, and continuing up to residue 50.
These a-helical regions of the bovine and yeast inhibitor pro-
teins are bound in a related way, and occupy the same
cleft between the C-terminal domains of the aDP- and
bDP-subunits. Most of the cleft lies between the C-terminal
ends of helices 1 and 2 in the C-terminal domains of the
bDP- and aDP-subunits. The entrance to the cleft from thecentral cavity is close to the C-terminal end of helix 1 in the
C-terminal domain of the bTP-subunit, and the exit to
the exterior surface of the F1-domain is completed by loops
between helices 1 and 2 in the C-terminal domain of the
aDP-subunit, and between helices 4 and 5 in the C-terminal
domain of the bDP-subunit.
Although there are similarities between the binding
modes of the a-helices of the yeast and bovine inhibitor pro-
teins, they are not identical. Global superimposition via the
Ca-atoms of the two inhibited structures demonstrates their
overall similarity (figure 4b; r.m.s. value 2.48 A˚), and the
structures of the inhibitors themselves in the inhibited com-
plexes are also similar (figure 4d ). However, in the
inhibited complexes, the a-helices of yeast I1–53 and
bovine IF1 do not lie exactly on the same axis; the a-helix
of the yeast protein follows a steeper path, relative to the
approximately vertical central stalk of F1-ATPase, and the
paths of the bound inhibitors diverge increasingly towards
the outside the F1-domain with an angle of ca 78 between
the a-helices. The most obvious reason for the slightly differ-
ent binding position of IF1 in the bovine and yeast enzymes
is a significant alteration in the conformation of residues
391–398 of the bDP-subunit of F1-ATPase; for example, the
positions of the Ca atoms of residues 392 and 393 differ by
1.6 and 2.7 A˚, respectively. Residues 391–398 of the bDP-sub-
unit help to form the ‘base’ of the binding pocket for IF1, and
the displacement of this region in the yeast enzyme relative to
the bovine enzyme accompanies the downward displacement
of the long a-helix of IF1. In both the bovine and yeast F1-IF1
(a)
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Figure 3. The structure of the F1-I1–53 complex from S. cerevisiae. The a-,
b-, g-, d- and 1-subunits are depicted in ribbon form in red, yellow, dark
blue, green and magenta, respectively, and residues 1–36 of I1–53 are light
blue. (a) Overall view of the complex viewed from the side with IF1 shown in
solid representation. (b) View (upwards from the foot of the central stalk)
along the axis of the g-subunit showing the position of the a-helix
of yeast IF1 in ribbon representation relative to the C-terminal domains of
a- and b-subunits.
Table 1. Data collection and refinement statistics for the complex between
yeast F1-ATPase and the yeast inhibitor protein, yI1–53. Statistics for the
highest resolution bin (2.64–2.5 A˚) are shown in parentheses.
space group P21
unit cell dimensions a, b, c (A˚); b (o) 118.2, 187.8, 181.8; 90.0
resolution range, A˚ 43.84–2.5 (2.64–2.5)
no. unique reflections 268 620 (38 863)
multiplicity 3.9 (3.9)
completeness, % 98.4 (97.6)
Rmerge
a 10.9 (74.8)
kI/s(I )l 8.7 (2.0)
B factor, from Wilson plot, A˚2 56.0
water molecules 735
R factorb 22.44%
free R factorc 26.19%
r.m.s. of bonds, A˚ 0.009
r.m.s. of angles, 8 1.2
aRmerge ¼
P
h
P
ijI(h)2 I(h)ij
P
h
P
iI(h)i, where I(h) is the mean
weighted intensity after rejection of outliers.
bR factor ¼PhlkjjFobsj 2 kjFcalcjj/
P
hlkjFobsj, where Fobs and Fcalc are
the observed and calculated structure factor amplitudes, respectively.
cRfree ¼
P
hkl,TjjFobsj 2 kjFcalcjj/
P
hkl,TjjFobsj, where Fobs and Fcalc are
the observed and calculated structure factor amplitudes, respectively, and T
is the test set of data omitted from refinement (5% in this case).
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4structures, residues 382–398 of the bDP-subunit are the region
that deviates most from the bovine ground state structure. Its
change in conformation is associated with the binding of IF1,
and it is reasonable to suggest that this difference between the
bovine and yeast F1-IF1 structures reflects how each enzyme
adapts in order to bind the different sequences of bovine
and yeast IF1, resulting in the slightly different binding
modes. These slightly differing binding modes are illustratedby the superimposed structures of the yeast and bovine
inhibitor proteins in the F1-IF1 complexes (figure 4b,c).
One specific interaction supports this interpretation. In the
bovine complex, bDP-D394 interacts with R32 of IF1 to form
a salt bridge, and the position of the loop containing residues
391–398 is influenced and displaced by gR133. In the yeast
enzyme, bD394 is conserved, but the bovine IF1 residue
R32 is replaced by F27 in yeast IF1, and the different confor-
mation of yeast bDP-residues 391–398 arises from bDP-D394
moving away from the hydrophobic side chain of yeast
inhibitor residue F27, and the position of the loop is no
longer influenced by gK135, the equivalent of bovine gR133
(see the electronic supplementary material, figure S1).
In consequence of these slightly different modes of
binding, there are both similarities and differences in the
detailed interactions between the inhibitor proteins and
their cognate F1-ATPases. The residues in the long a-helix
of bovine IF1 that contribute significantly to its binding to
bovine F1-ATPase have been identified by mutagenesis of
each residue in the a-helix, and by quantitative measurement
of the impact of each mutation on binding [10]. These experi-
ments have shown that the bovine a-helix is bound mainly by
hydrophobic interactions between residues Y33, F34, Q41,
L42 and L45 of the inhibitor protein and hydrophobic side
chains in the C-terminal domain of the bDP-subunit, and
F22 with the C-terminal domain of the bTP-subunit. In
addition, bovine inhibitor residue Q41 contributes by
making polar interactions with the same region of the bDP-
subunit, and there is a salt bridge between inhibitor residue
E30 and residue R408 in the bDP-subunit.
The structure of yF1-I1–53 shows that residues F17, E25
and F28 in yI1–53 and the equivalent residues, F22, E30
2.7
3.0
2.83.1
2.6
S4
T5
R9
S13
D15
g R9
g S12
(a)
(c)
(b)
(d)
Figure 4. The binding site for yeast I1–53 in the structure of yeast F1-ATPase. (a) The N-terminal loop region of the inhibitor protein (light blue) in juxtaposition
with the C-terminal helix of the g-subunit (dark blue). Dotted lines represent possible interactions with distances in angstrom. (b) View from the side of the central
stalk showing the orientations of the yeast and bovine inhibitor proteins (light blue and brown, respectively) relative to the central stalk. (c) View from outside the
F1-domain towards the g-subunit of the enzyme (dark blue) of the deep cleft between the C-terminal domains of the aDP- and bDP-subunits (red and yellow,
respectively) where the a-helical region of I1–53 (light blue) is bound. The position of the equivalent region of the bovine inhibitor protein in the structure of
bovine F1-I1–60 is shown in brown. (d ) View of the bovine inhibitor (brown) superposed onto the yeast inhibitor protein (light blue) via residues 22–25 and
17–20 in the bovine and yeast inhibitors, respectively.
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5and Y33, in the bovine inhibitor, interact with their cognate
F1-ATPases in the same manner. However, the other inter-
actions noted in the bovine complex are not conserved, but
the structure indicates that there are additional significant
interactions that are specific to the yeast complex. They are
a salt bridge between residue E2 of the inhibitor with residue
K361 in a-helix H of the aE-subunit (figure 4c), and between
R32 of the inhibitor and E398 and E405 in the bDP-subunit,
and an electrostatic interaction between inhibitor residue D15
and R9 in the g-subunit. In addition, inhibitor residues
D15 and R9 form an ionic interaction, evidently helping to
stabilize the loop from inhibitor residues 6–16 (figure 4a),and E33makes a backbone interaction with the amide nitrogen
of bDP-E454. There are other yeast specific interactions between
inhibitor residues T5, G6 and S11 with gS12, bDPD386 and
bDPE341, respectively.
In order to investigate some of these detailed differences
between the mode of binding of the yeast and bovine inhibi-
tors, residues E2, R9 and D15 of yeast IF1 were substituted
singly by alanine residues, as was residue R30, which has
been proposed to be important for forming the inhibited
complex [13]. In addition, two conserved leucine residues,
L37 and L40, were mutated to alanine. The correspond-
ing residues L42 and L45 interact with F1-ATPase in the
E2 R9 D1
5
R3
0
L3
7
L4
0
0
1
2
3
4
residue
K
im
u
t/K
iw
t
Figure 5. Influence of point mutation of selected residues in yI1–53 on its
inhibition of yeast F1-ATPase. The quantitative data from which the figure is
derived are given in table 2. Kiwt and Kimut are the dissociation constants for
the wild-type and mutant proteins, respectively.
Table 2. The binding and dissociation rate constants for yI1–53His
proteins containing point mutations.
mutation
kon 3 10
22
(mM21 s21)
koff 3 10
22
(s21)
Ki 3 10
22
(mM21)
none 58.3+ 5.6 2.8+ 0.3 4.8+ 0.7
E2A 12.3+ 0.3 0.1+ 0.0 1.0+ 0.1
R9A 11.4+ 0.8 1.9+ 0.2 17.0+ 2.1
D15A 170.7+ 2.1 1.4+ 0.6 0.8+ 0.4
R30A 127.8+ 6.8 0.3+ 0.2 0.2+ 0.2
L37A 19.1+ 1.0 0.4+ 0.4 2.2+ 1.9
L40A 11.6+ 1.2 1.8+ 0.3 15.6+ 2.9
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6bovine-inhibited complex, but no equivalent interaction is
found in yF1-I1–53. The results of the quantitative study of
the binding properties of each of these mutated proteins are
presented in table 2, and the effects of the mutations are sum-
marized in figure 5 as Kimut/Kiwt, the quotient of the
dissociation constants of the mutant and wild-type proteins.
Values of the quotient that are greater than and less than
unity correspond to proteins with decreased and increased
binding to F1-ATPase, respectively. The experiments show
that among the three N-terminal residues E2, R9 and D15
that were mutated, only the mutation of R9A had a signifi-
cant effect in increasing the quotient. However, because the
substitution D15A had little effect on the quotient (although
it changed the dynamics of binding significantly), the import-
ance of R9 in the formation of the inhibited complex does not
involve the formation of a salt bridge with residue D15. In the
absence of detailed structures of the mutated forms bound to
F1-ATPase, the impact of these mutations is difficult to
assess. The mutation L40A leads to an increase in the quotient,
indicating that this residue may have a role at some unidenti-
fied intermediate state in the pathway of the formation of the
final inhibited complex, as has been suggested for other resi-
dues in the bovine complex [10]. The substitution L37A had
little impact on the quotient, and the reason for its conservation
remains obscure. Finally, the mutation R30A, rather thanabolishing the inhibitory activity of yIF1, as reported [13],
decreased the quotient slightly.4. Discussion
4.1. The inhibited state
One highly significant difference between the structures of
the bovine and yeast inhibited complexes is in the occupancy
of nucleotides in the bE-subunit. In the bovine structure, there
is no nucleotide bound to this subunit, whereas in the yeast
complex, the still partially formed nucleotide binding site of
the bE-subunit is occupied by ADP, but without an accompa-
nying bound magnesium ion, despite the presence of 13 mM
magnesium sulphate during formation and crystallization of
the inhibited complex. In the yeast complex, the C-terminal
domains of the aDP- and aTP-subunits are displaced down-
wards and outwards, opening the aDP–bDP and aTP–bTP
interfaces slightly relative to the bovine complex. This open-
ing of these two interfaces is accompanied by small, but
significant, changes in the bE-subunit, where bE-Y345 and
bE-F424 remain sufficiently close to provide a pocket into
which the adenosine moiety of ADP can bind (albeit presum-
ably weakly). However, the amino acid side chains that are
involved in coordinating a magnesium ion indirectly by bind-
ing ligand water molecules (bE189, bE193 and bD256) have
moved away from the positions that provide the coordinating
environment (as found in the bDP- and bTP-subunits), and
the magnesium ion has been released from the bE-subunit
(figure 6). Thus, the present structure indicates that the mag-
nesium ion is released before ADP, and that the inhibitor has
arrested the catalytic cycle of ATP hydrolysis immediately
preceding the release of the nucleotide. Subsequent release
of the nucleotide would provide the bE-state observed in
the ‘ground state’ structures of F1-ATPase where no nucleo-
tide is bound to this subunit. One cautionary note is that it
is possible that the position of a-helix C3 in the C-terminal
domain of the bE-subunit, carrying residue bE-F424, could
be influenced by a contact in the crystal lattice with a-helix
b (residues 102–110) in the d-subunit of an adjacent
F1-complex (figure 7). As residues bE-F424A and bE-Y345
provide the pocket for binding the adenosine moiety of
ADP molecule, one possible interpretation is that a-helix C3
and the adenosine binding pocket are being held artificially
in this position by the crystal contact. However, one signifi-
cant argument against this interpretation is that a closely
related conformation of a bE-subunit, containing a bound
ADP molecule, also lacking an associated magnesium ion,
has been observed independently in a structure of bovine
F1-ATPase, known as F1-PH, crystallized in the presence of
nucleotides, magnesium ions and phosphonate, a chelating
agent for magnesium [11]. Global superimposition of the
bE-subunits in the yF1-I1–53 and F1-PH structures demonstrates
that theconformations andnucleotideoccupancies of thenucleo-
tide binding sites are essentially identical (r.m.s. value 0.79 A˚;
figure 7), and that there are no similar crystal contacts that
could influence the conformation of the bE-subunit in F1-PH.
Thus, both structures appear to represent a post-hydrolysis
pre-nucleotide release step in the catalytic cycle of the enzyme.
Alternatively, it can be argued that the presence of the
bound inhibitor protein distorts the structure of F1-ATPase
and leads to an inhibited state that is not on the active
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Figure 6. Change in the coordination of a magnesium ion in the active site of yeast F1-ATPase. (a) Hexacoordination of the magnesium ion (green) in the catalytic site of
the bDP-subunit. The ligands are provided by water molecule a–d (red), by the oxygen atom bO2 of ADP (or ATP), and by the b-hydroxy-group of bDP-T164. The water
molecules a–d are themselves hydrogen-bonded to other water molecules e–g (grey), by the oxygen atom bO1 of the nucleotide, and by the side chain functionalities
of residuesbDP-E189,bDP-R190 andbDP-D256. (b) Schematic of the disposition of the magnesium ion and bound ADP in the catalytic site of thebDP-subunit. The P-loop
sequence (upper left) helps to bind the magnesium ion and the nucleotide. The adenosine moiety of the nucleotide is bound in the hydrophobic pocket between the side
chains of residues bDP-Y345 and bDP-F424. Distances are given in angstrom, and those to the phosphate group are to the closest oxygen atom. (c) Rotation of g-subunit
driven by hydrolysis of ATP has opened the nucleotide binding domain of the subunit, converting thebDP-site to thebE-site. The catalytic ‘arginine finger’ residue, aR375
becomes disordered, and the coordination sphere of the magnesium ion is disrupted, releasing the metal ion. In the structure of yF1-I1–53, the inhibitor protein has
arrested the conversion of the site just before the formation of a fully ‘empty’ or ‘open’ site. The adenosine binding pocket is still intact, and ADP remains bound to the
subunit. In the final step of the conversion of the site to a fully formed bE-site (as observed in ‘ground state’ structures of F1-ATPase), the side chain of bE-F424 rotates
through 908, releasing the ADP molecule.
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7pathway of ATP hydrolysis. The close similarity of the
bE-subunit in the present and bovine F1-PH structures
(figure 7) can be taken as evidence against this interpretation.
There is no inhibitor protein bound to F1-PH, and the struc-
ture of the bE-subunit fits well with the interpretation that
it represents a post-hydrolysis, pre-nucleotide release state
in the catalytic cycle. The other structural changes in yeast
F1-ATPase, described earlier, associated with the presence
of the bound inhibitor are quite minor, as a global superim-
position of the current structure with the yeast ground state
structure demonstrates. Using ‘complex I’ from the yeast
ground state structure, the r.m.s values are 1.27 A˚ for the
whole complexes and 1.02 A˚ for the a3b3-domains. Therefore,
the preferred interpretation is that the structure represents an
intermediate in the catalytic cycle.
At present, there is no clear explanation of why the bovine
and yeast inhibitors arrest the catalytic cycle of their cognate
F1-ATPases at different points. Structures of the bovine
enzyme inhibited with the yeast inhibitor and vice versa
might help to elucidate this point. However, the observation
does raise the prospect that it may be possible to engineerinhibitor proteins to arrest the catalytic cycle of the active
enzyme at other points and thereby capture other states in
the catalytic cycle for structural analysis.
4.2. Mechanism of hydrolysis of ATP by F1-ATPase
One important conclusion reached from pairwise compari-
sons of all the known structures of F1-ATPase (with the
possible present exception of yeast F1-I1–53) is that the con-
formations of the catalytic sites in the three b-subunits of
the enzyme are not influenced by contacts between neigh-
bouring complexes in the lattice of the crystals used to
determine the structures [14], contrary to what has been pro-
posed [15–19]. Therefore, the structures of the catalytic sites
in a ‘ground state’ structure [20,21] and in a ‘transition
state’ analogue structure [22] define steps in the catalytic
pathway of ATP hydrolysis by F1-ATPase, as described pre-
viously and summarized in the electronic supplementary
material, figure S3. In the ‘ground state’ structure, the three
catalytic sites in the b-subunits of the enzyme have different
structures that are imposed by the asymmetry of the
bE F424
d N103
bE Y345
d S113
Figure 7. Comparison of the nucleotide binding pockets in the bE-subunits
in the structures of yF1-I1–53 and bovine F1-PH. The yeast and bovine
protein backbones are coloured yellow and pink, respectively. The side
chains of residues bE-F424 and bE-Y345 are red in the yeast enzyme and
pink in the bovine enzyme. They provide the pocket for binding the adeno-
sine moieties of the ADP molecules (blue and pink, respectively in the yeast
and bovine enzymes). In grey is shown a-helix b (residues 102–110) in the
d-subunit of an adjacent yeast F1-complex in the crystal lattice of yeast
F1-I1–53. It approaches to within 4 A˚ of a-helix C3 carrying bE-F424 in
the yeast structure. Thus, it makes a crystal contact that may influence the
position of a-helix C3 in the bE-subunit of the yeast enzyme.
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8g-subunit in the central stalk of the enzyme. They are usually
referred to as the bDP-, bTP- and bE-subunits. In a catalytic
cycle, each catalytic subunit passes through each of these
states, and the conversion of one state to another is brought
about by the rotation in 1208 steps of the central stalk in an
anticlockwise fashion (as viewed from the membrane
domain of the intact F-ATPase). Each 3608 rotation is
accompanied by the hydrolysis of three ATP molecules. In
the ground state structure, the bE-subunit has no nucleotide
bound to its nucleotide binding site. A 1208 rotary step con-
verts the bE-subunit to the bTP-subunit, entrapping an ATP
molecule in the nucleotide binding site. The next 1208 step
converts the bTP-subunit to the bDP-subunit, poising the site
for ATP hydrolysis. In the next 1208 step hydrolysis occurs;
the products magnesium.ADP and phosphate are released
from the enzyme and the bE-subunit is regenerated. In the
transition state analogue complex, the conformation of the
bE-subunit is intermediate between those of the bDP- and
bE-subunits, and it defines the state of the enzyme during
the cleavage of the g-phosphate from ATP by nucleophilic
attack by a water molecule, itself activated by bDP-E189
(bDP-E188 in the bovine enzyme). The present struc-
ture defines the conformation of the bE-subunit after the
bE-subunit in the transition state analogue structure, and
before the formation of that of the bE-subunit in the ground
state structure. In this state, the magnesium ion and phos-
phate have been released, but the nucleotide, ADP, is still
bound to the bE-subunit. It is incorporated into the pathway
of ATP hydrolysis (see electronic supplementary material,
figure S3). In two other NTPases, protein-1A (a member ofthe kinesin superfamily) [23] and rasp21 [24], it has been
shown similarly that following the hydrolysis of an NTP mol-
ecule, the magnesium ion is released before the product NDP.
The evidence concerning the order of release of the
magnesium ion and phosphate from F1-ATPase is at first
sight somewhat contradictory. In one of the three copies
of the enzyme in the ‘ground state’ crystal structure of
yeast F1-ATPase, phosphate (or sulphate) remains bound in
the bE-subunit in a position approximately 8 A˚ from the
g-phosphate of AMP–PNP in other nucleotide binding
sites, suggesting that it is released last [25]. However, there
is no phosphate bound in the other two copies of the
enzyme in the crystal lattice, or in the current structure,
suggesting that in the yeast enzyme, both the magnesium
ion and phosphate are released before the nucleotide in an
unknown order. In the bovine enzyme, the evidence also
suggests that both magnesium and phosphate are released
before the nucleotide. Although there is often density in
‘ground state’ structures of bovine F1-ATPase close to the
P-loop that can be interpreted as a bound anion, when this
density is modelled as a phosphate group the temperature
factors are very high, and there are only a few favourable
interactions with the protein. In addition, this feature lies in
a position midway between the a- and b-phosphates of a
bound nucleotide, and therefore could not be occupied at
the same time. Also, it is remote (7–8 A˚) from the clearly
identified phosphate binding site in the ‘half-closed’ bE-sub-
unit of the bovine transition state complex [22] and in the bE-
subunit of the yeast ‘ground state’ structure [25]. Therefore,
probably this site is an anion binding pocket that is occupied
fortuitously by phosphate or sulphate in the crystal structures,
and it does not represent a catalytically or physiologically rele-
vant phosphate binding site. In addition, in the structure of
bovine F1-PH where nucleotide is bound to the bE-subunit,
there is no bound phosphate or magnesium ion, suggesting
that they are released before the nucleotide.5. Material and methods
5.1. Analytical methods
Protein concentrations were estimated by the bicinchoninic
acid assay (Pierce, Thermo Scientific, Rockford, IL, USA).
Purified proteins were analysed by SDS–PAGE [26] and
stained with Coomassie blue dye. ATPase activity was
measured as described before [1]. Molecular masses of pro-
teins were measured following electrospray ionization in a
Quattro Ultima triple quadrupole mass spectrometer
(Waters, Milford, MA, USA).
5.2. Protein overexpression
A fragment of bovine IF1 from residues 14 to 60 fused to
glutathione-S-transferase (GST) with a C-terminal His6 tag
(known as bIF114–60-GST-His6) was over-expressed as
described before [10]. The sequence encoding residues 1–53
of IF1 from S. cerevisiae (yI1–53) was amplified by PCR
from a pRUN vector containing the coding sequence for
yeast IF1 containing the mutation E21A. This mutation
abolishes the pH sensitivity of the inhibitory action of the
inhibitor protein [13], and therefore it offers the prospect of
conducting crystallization experiments involving the
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9inhibited complex over a wider range of pH values. The
forward and reverse primers, respectively, were 50-TAATAC
GACTCACTATAGGG-30 and 50-CAGAAGCTTTTAAGAAT
CAATCTTCTTTCGTTG-30. The product was digested with
NdeI and HindIII, and cloned into the pRun plasmid.
yI1–53 was over-expressed for 12 h at 258C in Escherichia
coli strain BL21(DE3), as described previously [27].
The sequence encoding residues 1–53 of IF1 from
S. cerevisiae (yI1–53) together with a hexahistidine tag was
amplified by PCR from the yI1–53 pRun plasmid. Single
point amino acid substitutions were introduced into this
sequence with a series of pairs of synthetic complementary
oligonucleotide primers containing the mutated codons and
24 bases 50 and 30 of the codon, respectively. This region
was amplified by PCR, and extended in a second PCR with
primers flanking the 50 and 30 ends of the coding sequence
for yI1–53His. The modified sequences were cloned into
the pRun vector. The mutant proteins plasmids were over-
expressed from these expression plasmids for 4 h at 258C in
E. coli strain C41(DE3) [28].
5.3. Protein purification
The full-length bovine and yeast inhibitor proteins and
bIF114–60-GST-His6 were expressed and purified as
described previously [10]. The C-terminally truncated yeast
inhibitor protein yI1–53 containing the mutation E21A
and lacking a His-tag was used in crystallization experi-
ments. It was expressed as described before and purified at
48C as follows. Cells containing yI1–53 were suspended in
buffer containing 50 mM Tris–HCl, pH 7.4, 100 mM NaCl,
25 mM imidazole, 5 mM benzamidine hydrochloride, 5 mM
6-aminocaproic acid, 0.005 per cent phenylmethylsulfonyl
fluoride, 0.02 per cent sodium azide and one tablet per
50 ml of an EDTA-free protease inhibitor mixture (Roche
Diagnostics, Mannheim, Germany). The cells were disrupted
by two passages at 30 000 psi through a Z Plus 2.2 kW cell
disruptor (Constant Systems, Daventry, UK). The broken
cells were centrifuged (200 000g, 90 min), and the supernatant
was filtered through a membrane (0.22 mm pore size,
Sartorius, Go¨ttingen, Germany). The filtrate was heated to
608C under nitrogen for 20 min in the presence of 5 mM
dithiothreitol, centrifuged (9000g, 15 min) and dialysed for
12 h against a buffer containing 20 mM 1,3-diaminopropane,
pH 10.5, 1 mM EDTA, 1 mM benzamidine hydrochloride,
1 mM 6-aminocaproic acid, 0.005 per cent phenylmethyl-
sulfonyl fluoride and 0.02 per cent sodium azide. It was
loaded onto a Hi-Trap Q column (5 ml; GE Healthcare Bio-
Sciences AB, Uppsala, Sweden). Pure yI1–53 was recovered
in the breakthrough fractions. It was dialysed for 10 h against
20 mM Tris–HCl, pH 7.4, concentrated to 10 mg ml21 and
stored at 2258C. Cells containing mutant yI1–53His proteins
were broken as described earlier. They were applied to a Hi-
Trap nickel Sepharose column (GE Healthcare, Buckingham-
shire, UK) equilibrated in buffer containing 20 mM Tris–HCl,
pH 7.4, 10% (v/v) glycerol, 25 mM imidazole and 0.1 M
sodium chloride. yI1–53His and mutant forms were eluted
with a linear gradient of imidazole from 25 to 300 mM in a
total volume of 100 ml. Fractions containing the proteins
were pooled and dialysed for 4 h against 2 l of buffer consist-
ing of 20 mM Tris–HCl, pH 7.4, and concentrated with a
VivaSpin concentrator (molecular weight cut-off 5 kDa; Sar-
torius, Go¨ttingen, Germany). The analysis of the purifiedinhibitors by SDS–PAGE and their mass spectrometric charac-
terization are shown in electronic supplementary material,
figure S2 and table S1, respectively.
5.4. Purification of F1-ATPase
Saccharomyces cerevisiae (strain W303-1A; kindly provided
by B.L. Trumpower, Dartmouth Medical School, NH, USA)
was grown at 308C in an Applikon ADI 1075 fermenter
(Applikon, Schiedam, Netherlands) in 55 l of medium con-
sisting of 1 per cent yeast extract, 2 per cent peptone, 3%
v/v glycerol and adenine (0.055 g l21), pH 5.0. When the cul-
ture had reached late exponential phase (A600 8.0–9.0), the
cells were cooled to 188C and harvested at 18 000g in a con-
tinuous flow centrifuge. The following procedures were
carried out at 48C. Yeast cells (1.8 kg) were suspended in
2 vol (v/w) of buffer consisting of 100 mM Tris–HCl, pH
8.0, 650 mM sorbitol, 5 mM EDTA, 5 mM benzamidine,
5 mM 6-aminohexanoic acid, 0.005 per cent phenylmethyl-
sulfonyl fluoride and 0.2 per cent bovine serum albumin.
The suspension was passed through a Dyno-Mill bead mill
(W. A. Bachofen Machinery, Basel, Switzerland). The pH of
the broken cells was adjusted to pH 8.0 with Trizma (3 M).
Debris was removed by centrifugation at 7500g for 30 min.
Mitochondria were recovered from the supernatant by cen-
trifugation at 26 000g for 45 min. They were washed twice
with buffer containing 20 mM Tris–HCl, pH 7.5, 650 mM
sorbitol, 1 mM EDTA, 5 mM benzamidine, 5 mM 6-amino-
hexanoic acid and 0.005 per cent phenylmethylsulfonyl
fluoride, and re-suspended in buffer containing 50 mM
Tris–HCl, pH 8.0, 250 mM sucrose, 5 mM benzamidine
hydrochloride, 5 mM 6-aminocaproic acid and one tablet per
50 ml of an EDTA-free protease inhibitor mixture. Submito-
chondrial particles were prepared as described previously
[29]. F1-ATPase from a 50 ml portion of submitochondrial
particles (20 mg ml21) was released with chloroform [29] in
the presence of 2 mM ADP and 4 mM magnesium sulphate.
A tablet of an EDTA-free protease inhibitor cocktail, a sol-
ution (250 ml) containing 1 M of each of benzamidine
hydrochloride and 6-aminohexanoic acid, and of mixture
(250 ml in methanol) of 10 mM each of amastatin, besatatin,
pepstatin, leupeptin and diprotin were added. A twofold
molar excess of bIF114–60-GST-His6 and 100 ml of a neutral-
ized stock solution containing 500 mM ATP and 1 M
magnesium sulphate were added at 238C. Two further por-
tions of 100 ml of the same solution were added after 5 and
10 min. Methanol (10%), sodium chloride (150 mM) and
dithiothreitol (5 mM) were added to the solution of the inhib-
ited complex. It was applied at 48C with a flow rate of
0.5 ml min21 to a GSTrap affinity column (5 ml; GE Health-
care Bio-Sciences AB) equilibrated in buffer consisting of
50 mM Tris–HCl, pH 8.0, 10 per cent methanol, 250 mM
sucrose, 150 mM sodium chloride, 1 mM ATP, 2 mM mag-
nesium sulphate, 5 mM benzamidine hydrochloride, 5 mM
6-aminocaproic acid, 5 mM dithiothreitol and one tablet per
50 ml of an EDTA-free protease inhibitor mixture. The
column was washed with the same buffer, then transferred
to 238C and then washed again with the same buffer contain-
ing 50 mM EDTA and 50 mM EGTA, and no methanol or
DTT, and with ADP instead of ATP, to release the active
F1-ATPase. The recovered yeast F1-ATPase was passed
through a column of Superdex 200 (10/300; GE Healthcare
Bio-Sciences AB) at 0.5 ml min21. The specific activity of the
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10purified enzyme was 216 Umg
21. The analysis of the puri-
fied enzyme by SDS–PAGE and the mass spectrometric
characterization of its subunits are shown in the electronic
supplementary material, figure S2 and table S1, respectively.
5.5. Molecular mass estimation of inhibited complexes
All procedures were performed at 238C. F1-ATPase
(1 mg ml21; 100 ml) from S. cerevisiae in F1 buffer consisting
of 50 mM 3-morpholinopropanesulfonic acid, pH 6.6, 10%
(w : v) glycerol, 1 mM ADP, 2 mM magnesium sulphate and
0.002% (w/v) phenylmethanesulfonylfluoride was mixed
with a 15-fold molar excess of IF1 from S. cerevisiae
(10 mg ml21; 3 ml) or a fivefold molar excess of bovine IF1
(10 mg ml21; 1.3 ml) together with 1 mM ATP and 2 mM
magnesium sulphate (2 ml from a stock solution containing
20 mM ATP and 40 mM magnesium sulphate). Further por-
tions (2 ml) of the solution of ATP and magnesium sulphate
were added after 5 min and 10 min. The inhibited complexes
and the active F1-ATPase were applied separately to a column
of Superose 6 (10/300, GE Healthcare Bio-Sciences AB) pre-
equilibrated with F1 buffer. The absorbance of the eluate
was monitored at 280 nm, and fractions were analysed by
SDS–PAGE. The void volume of the column was determined
with Blue Dextran 2000. The column was calibrated with
thyroglobulin, catalase and the monomeric and dimeric
forms of ferritin.
5.6. Assay of inhibition of F1-ATPase
The ATP hydrolase activity of yF1-ATPase in the presence of
the various mutant inhibitors was measured with an ATP-
generating system as described before [1] by addition of
2.5 mg of F1-ATPase (specific activity; 101 mmol min
21 mg21)
to 1 ml of assay mixture at 378C. The absorbance at 340 nm
was recorded for 10 min with each inhibitor at six different
concentrations.
The rate constants of binding to and dissociation from
F1-ATPase, kon and koff, respectively, of each inhibitor protein
were measured from the exponential decay of the rate of
ATPase activity after addition of various amounts of inhibitor
protein as described previously [10]. The dissociation con-
stant, Ki, for the binding of the inhibitor to the enzyme was
calculated from Ki ¼ koff/kon.
5.7. Crystallization of the yeast F1-I1–53 complex
Active F1-ATPase (12 mg ml
21) was exchanged on a Biospin-
6 desalting column (BioRad, Hemel Hempstead, UK) into
crystallization buffer, prepared in D2O and consisting of
100 mM Bis–Tris propane, pH 7.5, 100 mM sucrose, 1 mM
ADP and 10 mM magnesium sulphate. Then, the enzyme
was inhibited at 238C with a fourfold molar excess of
yI1–53 (containing the mutation E21A and lacking a His-
tag) in the presence of 1 mM ATP and 2 mM magnesium
sulphate. Further portions (5 ml of a neutralized stock sol-
ution containing 200 mM ATP and 400 mM magnesium
sulphate ml21 protein solution) were added after 5 and
10 min. More than 95 per cent of the ATP hydrolysis activity
of the enzyme was inhibited. Sodium–potassium tartrate was
added to 100 mM, and the concentration of the protein
solution was adjusted to 10 mg ml21 with crystallization
buffer. Crystals were grown at 238C in 72 well micro-batchplates (Nunc International, Thermo Fisher Scientific,
Roskilde, Denmark) under filtered paraffin oil (BDH labora-
tory supplies, Poole, UK). The crystallization drops (4 ml)
contained a 1 : 1 mixture of protein solution and precipitant
solution (20–26% polyethylene glycol 3000 and 600 mM
NaCl prepared in D2O). Crystals appeared after 2 days and
were fully grown after two weeks. They were harvested
into a solution identical to the crystallization drop, but con-
taining an additional 1% (w/v) polyethylene glycol 3000.
They were cryoprotected with 20% (v/v) ethylene glycol
introduced in 5 per cent steps with 3 min at each step. The
cryoprotected crystals were harvested with Micro-Mount
cryoloops (MiTeGen, Ithaca, NY, USA), plunge-frozen in
liquid nitrogen and stored at 100 K.
5.8. Data collection
Diffraction data were collected at 100 K at 2.5 A˚ resolution
using a MX300 charge-coupled detector (Rayonix, Evanston,
IL, USA) on beamline I24 (l ¼ 0.977 A˚) at the Diamond Light
Source, Harwell, UK. The datawere processed with iMOSFLM
[30] and with programs POINTLESS, SCALA [31] and
CTRUNCATE [32] from the Collaborative Computational
Project Number 4 (CCP4) suite [33].
5.9. Solution and refinement of the structure
The structure of yF1-I1–53 from S. cerevisiaewas solved bymol-
ecular replacement with PHASER [34]. The startingmodel was
complex I taken from a ground state structure of F1-ATPase
from S. cerevisiae (protein data bank 2HLD) [25]. Nucleotides,
magnesium ions and water molecules were removed from
the model. Rigid body refinement, restrained refinement and
non-crystallographic symmetry refinement were performed
with REFMAC5 [35]. Manual rebuilding and the addition of
water molecules were performed with COOT [36], alternating
with refinement performed with REFMAC5. For calculations
of the Rfree value, 5 per cent of the diffraction data were
excluded from the refinement. Stereochemistry was assessed
with MOLPROBITY [37] and figures were prepared with PyMol
[38]. The structure was compared with other structures using
the SUPER alignment tool in PyMol with refinement cycles
set to zero. Coordinates and structure factors for the described
structure have been deposited with the protein data bank
under the accession code 3zia.6. Acknowledgements
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